Funder
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
Broad Institute | Stanley Center for Psychiatric Research, Broad Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Psychiatry and Mental health,Molecular Biology
Reference72 articles.
1. Marder SR, Cannon TD. Schizophrenia. N Engl J Med. 2019;381:1753–61.
2. Owen MJ, Sawa A, Mortensen PB. Schizophrenia. Lancet Lond Engl. 2016;388:86–97.
3. Millan MJ, Andrieux A, Bartzokis G, Cadenhead K, Dazzan P, Fusar-Poli P, et al. Altering the course of schizophrenia: progress and perspectives. Nat Rev Drug Discov. 2016;15:485–515.
4. Enna SJ, Bennett JP, Burt DR, Creese I, Snyder SH. Stereospecificity of interaction of neuroleptic drugs with neurotransmitters and correlation with clinical potency. Nature. 1976;263:338–41.
5. van Rossum JM. The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs. Arch Int Pharmacodyn Ther. 1966;160:492–4.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献